About Allux Medical, Inc.
Engineering relief for hyper-reactive airways
Allux Medical, Inc. is a clinical-stage medical device developer focused on treating hyper-reactive airway mucosa and inflammatory diseases of the upper and lower respiratory tract.
Who we are
Allux Medical, Inc. is a medical device company dedicated to developing minimally invasive, device-based therapies for patients living with chronic inflammatory and hyper-reactive conditions of the airway mucosa. Our work sits at the intersection of clinical airway science, advanced energy delivery, and patient-centered design — translating decades of ENT, pulmonology and biomedical engineering expertise into therapies that can be delivered safely in an office or outpatient setting.
What we treat
Hyper-reactive and inflammatory airway diseases affect hundreds of millions of people worldwide — chronic rhinitis, non-allergic and allergic rhinitis, chronic rhinosinusitis, post-nasal drip, cough-variant airway hyper-responsiveness, and related inflammatory conditions of the upper and lower airway. For many patients, daily medications offer only partial relief. Allux is building a platform of targeted, durable interventions designed to quiet over-reactive mucosa at the source.
Our Mission
Restore comfortable, predictable breathing — one airway at a time.
We believe airway disease deserves the same precision-engineered care that cardiology and oncology have enjoyed for decades. Allux Medical is building a portfolio of next-generation devices that combine targeted energy delivery, anatomically-aware design and elegant procedural workflows — giving clinicians a reliable, repeatable way to address the underlying neurovascular and inflammatory drivers of airway hyper-reactivity.
What drives us
Clinical rigor
Every device is grounded in published airway physiology, anatomical study and iterative bench-to-clinic validation.
Patient-first design
Minimally invasive, office-friendly procedures with rapid recovery — designed around real patients, not idealized cases.
Safety & durability
Targeted, tissue-selective energy delivery to maximize symptom relief while preserving healthy mucosa.
Physician partnership
Built with and for ENT, allergy and pulmonology specialists — workflows that fit the modern clinic.
Our approach
Allux develops handheld and catheter-based platforms that deliver precisely-controlled therapy to the submucosal structures responsible for airway hyper-reactivity. By focusing on the neural and glandular substrates that drive chronic congestion, runny nose, cough and inflammation, we aim to deliver long-lasting symptom relief in a single, well-tolerated procedure — without systemic medication.
Looking forward
From chronic rhinitis to inflammatory disorders of the lower airway, our pipeline is designed to expand the reach of device-based airway therapy. Allux Medical is partnering with leading clinicians, research centers and investors to bring these therapies through rigorous clinical study and into the hands of physicians worldwide.